Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease

Alzheimer disease (AD) is a complex neurodegenerative disorder, whose prevalence will dramatically rise by 2050. Despite numerous clinical trials investigating this disease, there is still no effective treatment. Many trials showed negative or inconclusive results, possibly because they recruited on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Babić, Mirjana, Švob Štrac, Dubravka, Mück-Šeler, Dorotea, Pivac, Nela, Stanić, Gabrijela, Hof, Patrick R., Šimić, Goran
Formato: Artigo
Idioma:Inglês
Publicado em: Croatian Medical Schools 2014
Assuntos:
Cerebrospinal Fluid Physiology and Movement
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4157375/
https://ncbi.nlm.nih.gov/pubmed/25165049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2014.55.347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados